Titan Biotech Ltd Quarterly Results

Gross Sales

54.35

46.5

35.17

38.28

39.89

Excise Duty

0

0

0

0

0

Net Sales

54.35

46.5

35.17

38.28

39.89

Other Operating Income

0

0

0

0

0

Other Income

1.32

0.72

1.38

1.59

0.32

Total Income

55.68

47.22

36.55

39.87

40.21

Total Expenditure

45.03

37.76

30.6

33.43

32.13

PBIDT

10.65

9.46

5.95

6.44

8.08

Interest

0.22

0.2

0.08

0.15

0.27

PBDT

10.43

9.26

5.87

6.29

7.81

Depreciation

1.21

1.15

0.84

1.18

1.1

Minority Interest Before NP

0

0

0

0

0

Tax

2.86

1.92

1.25

1.28

1.63

Deferred Tax

-0.5

0.03

0.02

0.03

0.08

Reported Profit After Tax

6.86

6.16

3.77

3.8

5

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

7.76

6.86

4.05

4.39

6.7

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

7.76

6.86

4.05

4.39

6.7

EPS (Unit Curr.)

9.4

8.3

4.9

5.31

8.1

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.26

8.26

8.26

8.26

8.26

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

19.59

20.34

16.91

16.82

20.25

PBDTM(%)

19.19

19.91

16.69

16.43

19.57

PATM(%)

12.62

13.24

10.71

9.92

12.53